Year(s) funded

Grant title

Grant agency type and number Grant title

Role on Project (if PI, multiple PI  or site PI, total direct costs)

Description of the major goalsDescription of the major goals

01/2009-12/2011

Platelet derived serotonin role in activation of hepatic satellite cell

National Natural Science Foundation of China   30872482

Co-Investigator (PI: Liu Chang)

The major goal of the study is to seek whether the platelet derived serotonin take part in the activation of the hepatic satellite cell.

Year(s) funded

Grant title

Grant agency type and number Grant title

Role on Project (if PI, multiple PI  or site PI, total direct costs)

Description of the major goalsDescription of the major goals

01/2013-12/2016

A ERCP automation equipment development.

National Natural Science Foundation of China   81270562

Co-Investigator (PI: Cao Gang)

The major goal of the study is to design and develop an automation equipment which can perform the ERCP.

01/2014-12/2016

Platelet derived serotonin role in hepatocellular carcinoma

Scientific Foundation of Second Affiliated Hospital, Xi’an Jiaotong University. RC(XM)201308

PI (¥ 30,000 - total direct costs)

This project seek the role of the platelet counts and platelet derived serotonin in hepatocellular carcinoma growth.

01/2015-12/2016

Chronic alcohol consumption accelerates hepatocellular carcinoma genesis  by intrahepatic translocation of intestinal bacteria

Natural Science Foundation of Shannxi Province of China    2015JM8389

PI (¥ 50,000 - total direct costs)

The major goal of the project is to define the role of  intestinal bacteria in alcoholic hepatocellular carcinoma genesis.

01/2017-12/2019

Chronic alcohol consumption accelerates hepatocellular carcinoma genesis via activation TLR9 mediated by the formation of NETs following intrahepatic translocation of intestinal bacteria

National Natural Science Foundation of China    81602401

PI (¥ 170,000 - total direct costs)

This study seek the reason why the incidence of hepatocellular carcinoma is increase during chronic alcohol consumption.

Innovation (date if applicable)

Patent, if any, pending or awarded /If described in print/on web, provide citation

Describe the influence or potential influence of the innovation on research or clinical care, including how the material is used locally (at HMS), regionally, nationally or internationally; if developed as a member of a team, describe your contribution (1-2 sentences)

A new auxiliary automatic equipment for encoscopic retrograde cholangio-pancreatography.

China Patent Application, 201010244305.9, filed November 24 2011/ http://cpquery.sipo.gov.cn

I, together with my colleague, designed an automatic equipment which can perfume ERCP by remote control. We only built an prototype of a machine for experiment test, but not put in to practice.  In this patent, I provide the idea.

A new auxiliary automatic equipment for percutaneous transhepatic cholangial drainage

China Patent Application, 2010102442836, filed December 29 2010/ http://cpquery.sipo.gov.cn

I, together with my colleague, designed an automatic equipment which can perfume PTCD by remote control. This equipment is still in development, but not put in to practice.  In this patent, I provide the idea.

A new auxiliary automatic equipment for vascular interventional technique.

China Patent Application, 201010244273.2, filed August  02 2010/ http://cpquery.sipo.gov.cn

I, together with my colleague, designed an automatic equipment which can perfume vascular interventional technique by remote control. This patent isn’t put into practice since less of funding support.  In this patent, I provide the idea.

A pulsatile blood pump for portal vein

China Patent Application, 201020211779.9, filed June 01 2010/ http://cpquery.sipo.gov.cn

This equipment which can increase the blood flow into the liver is use for the patient with portal hypertension. The equipment isn’t put in to clinical use since some deficient couldn’t be solved.